✦ LIBER ✦

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials

✍ Scribed by Nelson, M.; Amaya, G.; Clumeck, N.; Arns da Cunha, C.; Jayaweera, D.; Junod, P.; Li, T.; Tebas, P.; Stevens, M.; Buelens, A.; Vanveggel, S.; Boven, K.

Book ID: 126723771
Publisher: Oxford University Press
Year: 2012
Tongue: English
Weight: 261 KB
Volume: 67
Category: Article
ISSN: 0305-7453
DOI: 10.1093/jac/dks130

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of gender and race on the week 48

Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE

✍ S Hodder; K Arasteh; J De Wet; J Gathe; J Gold; P Kumar; L Mohapi; W Short; H Cr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB

P1233 EFFICACY AND SAFETY OF MK-5172 PLU

P1233 EFFICACY AND SAFETY OF MK-5172 PLUS RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION: FINAL RESULTS OF THE C-SPIRIT STUDY

✍ Gane, E.; Ben Ari, Z.; Mollison, L.; Zuckerman, E.; Bruck, R.; Baruch, Y.; Wahl, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Boceprevir versus placebo with pegylated

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial

✍ Sulkowski, Mark; Pol, Stanislas; Mallolas, Josep; Fainboim, Hugo; Cooper, Curtis 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 333 KB

Safety and efficacy of adefovir dipivoxi

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

✍ Y Benhamou; M Bochet; V Thibault; V Calvez; MH Fievet; P Vig; CS Gibbs; C Brosga 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 97 KB

P1234 SAFETY AND EFFICACY OF MK-5172 PLU

P1234 SAFETY AND EFFICACY OF MK-5172 PLUS PEGINTERFERON ALFA-2b AND RIBAVIRIN (PR) IN CIRRHOTIC AND NON-CIRRHOTIC TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS (HCV) GENOTYPE (G)1 INFECTION

✍ Hezode, C.; Bruno, S.; Jacobson, I.; Serfaty, L.; Kwo, P.; Zhou, A.; Gilbert, C. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

O10 SAFETY AND EFFICACY OF THE ALL-ORAL

O10 SAFETY AND EFFICACY OF THE ALL-ORAL REGIMEN OF MK-5172/MK-8742 ± RIBAVIRIN IN TREATMENT-NAIVE, NON-CIRRHOTIC, PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION: THE C-WORTHY STUDY

✍ Hezode, C.; Serfaty, L.; Vierling, J.M.; Kugelmas, M.; Pearlman, B.; Sievert, W. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB